Search hospitals > Florida > Orlando
Orlando Clinical Research Center
Claim this profileOrlando, Florida 32809
Global Leader in Liver disease
Global Leader in Kidney Failure
Conducts research for Renal Disease
Conducts research for Healthy Subjects
Conducts research for Chronic Renal Failure
271 reported clinical trials
1 medical researcher
Summary
Orlando Clinical Research Center is a medical facility located in Orlando, Florida. This center is recognized for care of Liver disease, Kidney Failure, Renal Disease, Healthy Subjects, Chronic Renal Failure and other specialties. Orlando Clinical Research Center is involved with conducting 271 clinical trials across 154 conditions. There are 1 research doctors associated with this hospital, such as Thomas C Marbury.Top PIs
Clinical Trials running at Orlando Clinical Research Center
Liver disease
Healthy Subjects
Kidney Failure
Renal Disease
Breast Cancer
Liver Dysfunction
Hepatic Insufficiency
Schizophrenia
Breast cancer
Bacterial Infection
Nemtabrutinib
for Liver Disease
The purpose of this study is to compare the plasma pharmacokinetics (PK) of nemabrutinib (MK-1026) following a single oral dose of nemtabrutinib in participants with moderate hepatic impairment to that of healthy matched control participants and to evaluate the safety and tolerability of nemtabrutinib.
Recruiting1 award Phase 12 criteria
Golcadomide
for Liver Disease
The purpose of this study is to assess the drug levels and safety of golcadomide (BMS-986369) in adult participants with moderate and severe Hepatic Impairment (HI), and in matched healthy control participants with normal hepatic function.
Recruiting1 award Phase 1
Palovarotene
for Liver Disease
The main aim of this study is to understand how moderate and severe liver impairment (based on the Child-Pugh classification) affects the body's processing of a single dose of 10 mg maximum of palovarotene, compared to healthy participants with normal liver function. The study will also assess the safety and tolerability of the single dose of palovarotene. Participants will be enrolled in stages and divided into three groups based on their liver function: * Group 1: Healthy participants with normal liver function * Group 2: Participants with moderate liver impairment * Group 3: Participants with severe liver impairment (only enrolled if Group 2 results are safe and acceptable) Blood samples will be taken to assess how the drug binds to proteins in the blood. Participants will undergo various safety checks and procedures. Participants will stay in the clinical unit until Day 5 for these assessments and will return on Day 10 for a final visit.
Recruiting1 award Phase 11 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Orlando Clinical Research Center?
Orlando Clinical Research Center is a medical facility located in Orlando, Florida. This center is recognized for care of Liver disease, Kidney Failure, Renal Disease, Healthy Subjects, Chronic Renal Failure and other specialties. Orlando Clinical Research Center is involved with conducting 271 clinical trials across 154 conditions. There are 1 research doctors associated with this hospital, such as Thomas C Marbury.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.